AI-generated summary
The authors report a case series of 203 patients with age-related macular degeneration treated with low-level laser therapy at 780 nm, with 10 control patients given mock treatment. They found visual acuity improved in most treated eyes, with no adverse effects observed, but the study was retrospective and lacked a comparable control group.
- Participants
- 203
- Who or what was studied
- Patients with beginning (dry) or advanced (wet) age-related macular degeneration, mean age about 63 to 64 years, with and without cataracts, plus 10 control patients receiving mock treatment
- Wavelengths
- 780 nm
- Limits stated in the abstract
- The study was a retrospective case series with only 10 control patients, so no robust comparison group was used and causal claims cannot be firmly drawn.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
Objective
The objective of this study of a case series was to examine the effects of low-level laser therapy (LLLT) in patients with age-related macular degeneration (AMD).
Background Data
AMD affects a large proportion of the elderly population; current therapeutic options for AMD are limited, however.
Patients And Methods
In total, 203 patients (90 men and 113 women; mean age 63.4 +/- 5.3 y) with beginning ("dry") or advanced ("wet") forms of AMD (n = 348 eyes) were included in the study. One hundred ninety-three patients (mean age 64.6 +/- 4.3 y; n = 328 eyes) with cataracts (n = 182 eyes) or without cataracts (n = 146 eyes) were treated using LLLT four times (twice per week). A semiconductor laser diode (780 nm, 7.5 mW, 292 Hz, continuous emission) was used for transconjunctival irradiation of the macula for 40 sec (0.3 J/cm2) resulting in a total dose of 1.2 J/cm2. Ten patients (n = 20 eyes) with AMD received mock treatment and served as controls. Visual acuity was measured at each visit. Data were analyzed retrospectively using a t-test.
Results
LLLT significantly improved visual acuity (p < 0.00001 versus baseline) in 162/182 (95%) of eyes with cataracts and 142/146 (97%) of eyes without cataracts. The prevalence of metamorphopsia, scotoma, and dyschromatopsia was reduced. In patients with wet AMD, edema and bleeding improved. The improved vision was maintained for 3-36 mo after treatment. Visual acuity in the control group remained unchanged. No adverse effects were observed in those undergoing therapy.
Conclusion
In patients with AMD, LLLT significantly improved visual acuity without adverse side effects and may thus help to prevent loss of vision.
Abstract reproduced under the CC BY license. Source: PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 780 nm
- Energy density (fluence)
- 0.3 J/cm2, 1.2 J/cm2
- Power
- 7.5 mW
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Age-related macular degeneration, Low-level laser therapy, Laser, Control group, Dose. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.